Diabetes
| T2D Therapy
Diabetes
T2D Therapy

Similar Hypoglycemia Duration with Once-Weekly Icodec vs. Degludec or Glargine U100 in Insulin-Treated T2D—A Post Hoc CGM Analysis from ONWARDS 2 and 4

book_2 Source: ADA 2023 - Poster Session
calendar_today Published on Medfyle: July 2023
headphones 4 min

In this medfyle

Duration of hypoglycemic episodes <70 mg/dL was similar for once weekly insulin icodec versus once daily degludec or glargine U100.

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Presenting Author

Harpreet S Bajaj, MD, MPH

LMC Diabetes & Endocrinology,
Brampton, ON, Canada

About this Medfyle
Read more arrow_downward Hide arrow_upward

This content is intended for an international audience of non-UK healthcare professionals. The content is made available through a licensing agreement between Infomedica and the American Diabetes Association (ADA).

The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content. The viewpoints expressed may not represent Infomedica, Medfyle, or the ADA.

©2023 Infomedica-Medfyle. All rights reserved


Feedback